Thesis Abstract

The increasing prevalence of drug-resistant bacteria poses a significant threat to public health worldwide. As a result, there is a pressing need to explore alternative antimicrobial agents to combat this growing issue. This research project focuses on investigating the antimicrobial properties of plant extracts against drug-resistant bacteria. The study aims to evaluate the effectiveness of various plant extracts in inhibiting the growth of drug-resistant bacterial strains through laboratory experiments and analysis. The research begins with a comprehensive literature review to establish the background of the study and identify gaps in existing knowledge regarding the antimicrobial properties of plant extracts. Various studies on the subject will be critically analyzed to provide a solid foundation for the research. The methodology chapter outlines the experimental design, including the selection of plant extracts, bacterial strains, and antimicrobial testing methods. The research methodology will adhere to standard protocols to ensure the reliability and validity of the results. The findings chapter presents the results of the antimicrobial testing, including the inhibitory effects of different plant extracts on drug-resistant bacterial strains. The data will be analyzed and interpreted to determine the potential of plant extracts as alternative antimicrobial agents. The discussion chapter delves into the implications of the findings, comparing them to existing literature and discussing the significance of the results in the context of combating drug-resistant bacteria. The conclusion summarizes the key findings of the study and offers insights into the potential applications of plant extracts as antimicrobial agents against drug-resistant bacteria. The research contributes to the growing body of knowledge on alternative antimicrobial agents and provides valuable information for future research in this field. Overall, this thesis contributes to the understanding of the antimicrobial properties of plant extracts and their potential role in addressing the challenge of drug-resistant bacteria.

Thesis Overview

The project titled "Investigation of the antimicrobial properties of plant extracts against drug-resistant bacteria" aims to explore the potential of plant extracts as alternative antimicrobial agents against drug-resistant bacteria. With the rise of antibiotic resistance posing a significant threat to public health, there is an urgent need to discover novel antimicrobial compounds. Plant extracts have long been used in traditional medicine for their antimicrobial properties, and this project seeks to scientifically investigate and validate their effectiveness. The research will involve the collection of various plant samples known for their antimicrobial properties. These samples will be extracted using appropriate methods to obtain the bioactive compounds present in the plants. The antimicrobial activity of these extracts will be evaluated against a panel of drug-resistant bacteria strains commonly encountered in clinical settings. The project will also aim to identify the specific bioactive compounds responsible for the antimicrobial activity of the plant extracts. This will involve employing various analytical techniques such as chromatography and spectroscopy to isolate and characterize the active components. Understanding the mechanism of action of these compounds will provide valuable insights into their potential use as antimicrobial agents. Additionally, the research will assess the potential synergistic effects of combining plant extracts with conventional antibiotics. This approach may help enhance the antimicrobial activity of existing drugs and overcome resistance mechanisms developed by bacteria. Overall, this project seeks to contribute to the growing body of knowledge on alternative antimicrobial strategies and provide valuable insights into the potential use of plant extracts in combating drug-resistant bacteria. The findings of this research could have significant implications for the development of new antimicrobial therapies and contribute to addressing the global challenge of antibiotic resistance.